03rd February 2022 | Pharma Updates
Bharat Biotech plant at Manjari ready to make Covid vaccines
Along with the FDA team, district collector Rajesh Deshmukh visited the plant. The officials are now waiting for the DCGI approval.
Justify Anti-Cancer Drug Dose Modifaction Criteria: CDSCO Asks GSK
This came after the drug major introduced the proposed phase 2 DREAMM-14 review protocol number 209628; Version 1.0 before the authority.
Alvotech Pens Licensing Agreement with BiosanaPharma
This partnership is for the development of AVT23, also known as BP001.
Starpharma signs Deal in Saudi Arabia
VIRALEZE is now registered in over 30 nations, including India, New Zealand, Europe, Vietnam, and Saudi Arabia, and is also available online in a few regions.
Eli Lilly and Entos to Develop Therapies for Multiple Neurologic Indications
Eli Lilly and Company has inked a research and collaboration agreement with Entos Pharma for neurological disorders patients.
LEO Pharma Sells Mobile Applications to Medable
Medable Inc. a software provider for patient-centred clinical trials, has completed the acquisition of LEO Innovation Labs.
CordenPharma buys Three Manufacturing Facilities from Vifor Pharma
CordenPharma, a leading Contract Development & Manufacturing Organization has acquired three manufacturing units from Vifor Pharma.
Janssen Acquires Anakuria Therapeutics
According to the terms of the agreement, J&J subsidiary is now the owner of all outstanding shares of Anakuria Therapeutics, Inc.
First Generic Drug for the Treatment of Dry Eyes
The first generic of Restasis increases tear production in patients whose eyes are affected by ocular inflammation.
Syros gets US FDA Orphan Drug Designation for Tamibarotene
Tamibarotene is developed for the treatment of patients with myelodysplastic syndrome.
